LPL Financial’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,022
| Closed | -$44.7K | – | 4994 |
|
|
2024
Q1 | $44.7K | Buy |
3,022
+3
| +0.1% | +$44 | ﹤0.01% | 4704 |
|
|
2023
Q4 | $43.8K | Buy |
3,019
+301
| +11% | +$4.37K | ﹤0.01% | 4601 |
|
|
2023
Q3 | $29.3K | Hold |
2,718
| – | – | ﹤0.01% | 4518 |
|
|
2023
Q2 | $35.1K | Hold |
2,718
| – | – | ﹤0.01% | 4413 |
|
|
2023
Q1 | $35.9K | Hold |
2,718
| – | – | ﹤0.01% | 4325 |
|
|
2022
Q4 | $40.8K | Sell |
2,718
-113
| -4% | -$1.7K | ﹤0.01% | 4269 |
|
|
2022
Q3 | $33K | Sell |
2,831
-768
| -21% | -$8.95K | ﹤0.01% | 4246 |
|
|
2022
Q2 | $41K | Hold |
3,599
| – | – | ﹤0.01% | 4231 |
|
|
2022
Q1 | $108K | Hold |
3,599
| – | – | ﹤0.01% | 3944 |
|
|
2021
Q4 | $95K | Buy |
3,599
+1,042
| +41% | +$27.5K | ﹤0.01% | 4136 |
|
|
2021
Q3 | $93K | Buy |
2,557
+948
| +59% | +$34.5K | ﹤0.01% | 4132 |
|
|
2021
Q2 | $70K | Buy |
+1,609
| New | +$70K | ﹤0.01% | 4088 |
|
|
2020
Q1 | – | Sell |
-1,150
| Closed | -$25K | – | 3366 |
|
|
2019
Q4 | $25K | Hold |
1,150
| – | – | ﹤0.01% | 3282 |
|
|
2019
Q3 | $22K | Hold |
1,150
| – | – | ﹤0.01% | 3241 |
|
|
2019
Q2 | $30K | Sell |
1,150
-200
| -15% | -$5.22K | ﹤0.01% | 3212 |
|
|
2019
Q1 | $35K | Hold |
1,350
| – | – | ﹤0.01% | 3118 |
|
|
2018
Q4 | $31K | Buy |
1,350
+200
| +17% | +$4.59K | ﹤0.01% | 3009 |
|
|
2018
Q3 | $37K | Hold |
1,150
| – | – | ﹤0.01% | 3173 |
|
|
2018
Q2 | $33K | Buy |
+1,150
| New | +$33K | ﹤0.01% | 3141 |
|